Search Within

Roni Tamari

  1. "Dean Carlow"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
Groups
  1. Bone Marrow Transplant (11)
  2. CTCR Scholars (11)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. Department of Pathology and Laboratory Medicine (11)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Dean Carlow (11)
  2. Gunjan Shah (11)
  3. Sergio Giralt (11)
  4. Guenther Koehne (10)
  5. Sean Devlin (10)
  6. Boglarka Gyurkocza (7)

More People

Years
  1. 2022 (1)
  2. 2018 (4)
  3. 2017 (6)
Publications
  1. Biology of Blood and Marrow Transplantation (8)
  2. Blood (2)
  3. Clinical Pharmacokinetics (1)
Publishers
  1. Elsevier Inc. (8)
  2. American Society of Hematology (2)
  3. Adis International Ltd (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: Towards individualized dosing regimens
    Journal Article

    Shah, G. L.; Boelens, J. J.; Carlow, D.; Lin, A.; Schofield, R.; Cruz Sitner, N.; Alperovich, A.; Ruiz, J.; Proli, A.; Dahi, P.; more...
    Clinical Pharmacokinetics (2022)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Impact of toxicity on survival for older adult patients after CD34(+) selected allogeneic hematopoietic stem cell transplantation
    Journal Article

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Borrill, T.; Carlow, D. C.; Avecilla, S. T.; Meagher, R. C.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Toxicities and outcomes in the first year after ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Herrera, D. A. A.; Scordo, M.; Shah, G. L.; Devlin, S. M.; Maloy, M.; Nieves, J.; Cho, C.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Post-transplant toxicities and outcomes in long-term survivors of ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save